Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA
  • Print
  • Share
  • E-mail
-

Browse FDA-TRACK Program Areas or Administrative Offices Index

Take Time to Care Outreach Program

Description: Disseminate digital and print FDA health and safety information to diverse populations of women. OWH will collaborate with other FDA partners and external organizations to raise awareness about FDA resources to help women and health professionals make informed decisions about the use of FDA-regulated products.

FY21 Activities

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Targeted Outreach
1. Promote OWH pregnancy and maternal health resources to targeted rural communities via Twitter FY21 Q1
 Completed 11/30/2020
2. Conduct digital ad campaign to promote OWH pregnancy and maternal health resources FY21 Q1
 Completed 11/30/2020
3. Promote CBD and Women scientific public conference across digital platforms FY21 Q1
 Completed 11/30/2020
4. Conduct targeted outreach to HBCU's as part of College Women's Campaign FY21 Q4
 Completed 5/31/2021
B. Update OWH Publications and Translate OWH Publications in Various Languages
1. Translate and update relevant OWH publications for distribution electronically FY21 Q4
 Completed 8/5/2021
2. Promote availability of publications in various languages FY21 Q4
 Completed 9/30/2021
3. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY21 Q4
 Completed 9/30/2021
C. Knowledge and News on Women's Health (KNOWH) Outreach
1. Develop relevant materials promoting diabetes outreach to target audiences FY21 Q4
 Delayed
2. Conduct national promotion of materials via social media and electronic platforms FY21 Q4
 Delayed
3. Conduct digital ad campaign to promote diabetes resources FY21 Q4
 Delayed
D. Mammography Awareness Outreach
1. Update Pink Ribbon Sunday Program Guide (print and electronic) FY21 Q4
 Completed 10/20/2021
2. Conduct updated Pink Ribbon Guide/mammography awareness to stakeholders via electronic and social media FY21 Q4
 Delayed
3. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY21 Q4
 Completed 10/29/2021
E. Stakeholder Outreach and Patient Engagement
1. Disseminate monthly electronic e-newsletter blasts of relevant FDA announcements to stakeholders FY21 Q4
 Completed 9/30/2021
2. Conduct monthly social media outreach to disseminate FDA health and safety information to the public and stakeholders FY21 Q4
 Completed 9/30/2021
3. Conduct College Women's Campaign outreach activities FY21 Q3
 Completed 5/26/2021
4. Conduct National Women's Health Week Promotion FY21 Q3
 Completed 5/15/2021
5. Collaborate with federal agencies and stakeholders to promote various women's health topics via social media FY21 Q4
 Completed 9/30/2021
6. Develop OWH KNOW blog posts on various women's health topics FY21 Q4
 Completed 9/30/2021

FY20 Activities

Briefing Status: COMPLETED

Prior Briefing Status: COMPLETED

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. HIV and Women Outreach
1. Update HIV and women print publications and online content FY20 Q1
 Completed 12/29/2019
2. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY20 Q1
 Completed 12/31/2019
3. Promote HIV and Women research data FY20 Q1
 Completed 12/31/2019
4. Conduct 1 digital ad campaign to promote HIV and women resources FY20 Q2
 Completed 3/30/2020
B. Mammography Awareness Promotion
1. Conduct #PinkSunday promotion targeting faith-based institutions and other partners FY20 Q1
 Completed 10/31/2019
2. Disseminate Pink Ribbon Sunday program digital and print resources FY20 Q1
 Completed 10/31/2019
3. Promote mammography screening to minority women FY20 Q1
 Completed 10/31/2019
4. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY20 Q1
 Completed 10/31/2019
C. OWH 25th Anniversary
1. Develop 25th Anniversary graphics and content to recognize FDA OWH contributions FY20 Q1
 Completed 11/30/2019
2. Promote 25th Anniversary internally and externally via social media, electronic communications and with select stakeholder activities FY20 Q1
 Completed 12/31/2019
D. Women and Cardiovascular Disease Video
1. Develop video to promote heart health awareness for women FY20 Q1
 Completed 12/30/2019
2. Develop outreach promotional plan FY20 Q1
 Completed 12/31/2019
3. Promote video during American Heart Month (February) to women and stakeholders via social media and electronic communications FY20 Q2
 Completed 2/29/2020
4. Conduct digital ad campaign to promote video FY20 Q2
 Completed 2/29/2020
E. Stakeholder Outreach and Patient Engagement
1. Disseminate monthly electronic e-newsletter and relevant FDA announcements to women's health stakeholders FY20 Q4
 Completed 8/20/2020
2. Conduct monthly social media outreach to disseminate FDA safety and women's health information to the public and women's health stakeholders FY20 Q4
 Completed 9/30/2020
3. Conduct targeted College Women's Campaign outreach FY20 Q4
 Completed 8/31/2020
4. Conduct National Women's Health Week Promotion FY20 Q4
 Completed 5/16/2020
5. Collaborate with stakeholders to promote various women's health topics via social media (e.g., twitter chats) FY20 Q4
 Completed 9/30/2020

FY19 Activities

Briefing Status: ON HOLD

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Cardiovascular Disease Promotion
1. Develop an evergreen toolkit as a resource for stakeholders in English and Spanish FY19 Q2
 Completed 6/30/2019
2. Participate in Twitter chats with agency partners to promote heart health in women FY19 Q2
 Completed 3/1/2019
3. Conduct national publication promotion via Pueblo Distribution Center (GPO) to disseminate OWH and other FDA publications to women FY19 Q2
 Completed 3/1/2019
4. Promote cardiovascular disease research FY19 Q3
 Completed 6/30/2019
B. HIV and Women Outreach
1. Update HIV and women print and online publications FY19 Q3
(FY20 Q2)
 Completed 12/29/2019
2. Conduct 1 digital ad campaign to promote HIV and women resources FY19 Q3
(FY20)
 Completed 12/31/2019
3. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY19 Q4
(FY20)
 Completed 12/31/2019
4. Promote HIV and Women research data FY19 Q4
(FY20)
 Completed 12/31/2019
C. Mammography Awareness Promotion
1. Conduct #PinkSunday promotion targeting faith based institutions and other partners FY19 Q4
(10/31/2019)
 Completed 10/31/2019
2. Disseminate Pink Ribbon Sunday program digital and print resources FY19 Q4
(10/31/2019)
 Completed 10/31/2019
3. Promote mammography screening to minority women FY19 Q4
(10/31/2019)
 Completed 10/31/2019
4. Conduct national publication promotion via GPO to disseminate OWH and other FDA publications to women FY19 Q4
(10/31/2019)
 Completed 10/31/2019
D. Stakeholder Outreach and Patient Engagement
1. Disseminate weekly electronic e-mail updates to womens health stakeholders FY19 Q4
 Completed 9/30/2019
2. Conduct monthly social media outreach to disseminate FDA health and safety information to the public and womens health stakeholders FY19 Q4
 Completed 9/30/2019
3. Conduct targeted College Womens Campaign Outreach FY19 Q3
 Completed 9/30/2019
4. Conduct National Womens Health Week Promotion FY19 Q3
 Completed 5/20/2019
5. Promote 25th Anniversary of FDA OWH internally and externally with partners and stakeholders FY19 Q4
 Completed 9/30/2019

FY18 Activities

Briefing Status: DELAYED

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Women Caregivers Promotion
1. Develop new caregiver fact sheet and flyer FY18 Q2
 Completed 9/10/2018
2. Update caregiver tips resource webpage FY18 Q2
 Completed 12/31/2017
3. Conduct 1 digital ad campaign to promote caregiver resources FY18 Q2
 Completed 9/23/2018
4. Disseminate print caregiver fact sheets FY18 Q4
 Completed 9/6/2018
B. Mammography Awareness Promotion
1. Sponsor National Mammography Day Thunderclap FY18 Q1
 Completed 10/20/2017
2. Conduct #PinkSunday Promotion targeting faith-based institutions and other partners FY18 Q1
 Completed 10/20/2017
3. Promote mammography screening to minority women FY18 Q3
 Completed 6/1/2018
4. Disseminate Pink Ribbon Sunday Program digital and print resources FY18 Q4
 Completed 9/30/2018
C. Safe Medication Use Outreach
1. Develop and disseminate new fact sheet for women on safe use of opioids and other pain medications FY18 Q3
 Completed 9/27/2018
2. Conduct 3 national publication promotions via Pueblo Distribution Center (GPO) to disseminate OWH and other FDA publications to women FY18 Q4
 Completed 9/30/2018
3. Disseminate print and digital consumer resources on medication use during pregnancy FY18 Q4
 Completed 9/30/2018
D. General Stakeholder and Patient Engagement
1. Disseminate monthly electronic email updates to women’s health stakeholders FY18 Q4
 Completed 9/30/2018
2. Conduct monthly social media outreach to disseminate FDA health and safety information to women’s health stakeholders FY18 Q4
 Completed 9/1/2018
3. Develop and disseminate quarterly social media toolkits for partner organization FY18 Q4
 Completed 9/6/2018
4. Conduct National Women’s Health Week Promotion FY18 Q3
 Completed 5/19/2018

FY17 Activities

Briefing Status: COMPLETED

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date
A. Medication Use During Pregnancy
1. Host one Twitter Chat FY17 Q1
 Completed 10/27/2016
2. Conduct Digital Ad Campaign to promote medicine and pregnancy webpage FY17 Q3
 Completed 5/21/2017
3. Translate and adapt medicine and pregnancy fact sheet in select foreign languages FY17 Q3
 Completed 5/15/2017
4. Disseminate print and digital consumer publications FY17 Q4
 Completed
5. Conduct outreach at national health conferences to raise awareness among health professionals about FDA resources on medication use during pregnancy FY17 Q4
 Completed 9/15/2017
B. Select Womens Health Conditions
1. Conduct Mammography Awareness Promotion FY17 Q1
 Completed 10/26/2016
2. Update Menopause Resource Webpage FY17 Q3
 Completed 9/14/2017
3. Conduct two special promotions to disseminate FDA resources for women on heart health, diabetes, and other chronic diseases FY17 Q4
 Completed 8/1/2017
C. General Outreach
1. Conduct National Womens Health Week Promotion FY17 Q3
 Completed 5/20/2017
2. Translate, adapt and disseminate women in clinical fact sheet in select foreign languages FY17 Q3
 Completed 5/15/2017
3. Disseminate Monthly Electronic Email Updates to Women’s Health Stakeholders FY17 Q4
 Completed 9/22/2017
4. Develop and disseminate two social media toolkits for partner organizations FY17 Q4
 Completed 9/14/2017

Foot Notes

  • The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-